Skip to main content
. 2022 Sep 10;19(4):1128–1143. doi: 10.1080/15548627.2022.2116676

Figure 1.

Figure 1.

RBSDV P10 protein binds to PtdIns(3,5)P2. (A) The binding between RBSDV crude extract and phospholipids. (B) The binding between different phospholipids and P10 protein (1.5 μg/mL). (C) The binding between P10 protein at a gradient concentration and phospholipids. (D) The binding between P10 truncated proteins (50 μg/mL) and phospholipids. (E) The binding between P10 peptides (50 μg/mL) and phospholipids. The binding was analyzed by lipid binding assay. LPA, lysophosphatidic acid; LPC, lysophosphatidylcholine; S1P, sphingosine-1-phosphate; C1P, ceramide-1-phosphate; PtdIns3P, phosphatidylinositol-3-phosphate; PtdIns4P, phosphatidylinositol-4-phosphate; PtdIns5P, phosphatidylinositol-5-phosphate; PtdIns(3,5)P2, phosphatidylinositol-3,5-bisphosphate; PtdIns(4,5)P2, phosphatidylinositol-4,5-bisphosphate; PtdIns(3,4)P2, phosphatidylinositol-3,4-bisphosphate; PtdIns(3,4,5)P3, phosphatidylinositol-3,4,5-triphosphate; PE, phosphatidylethanolamine; PC, phosphatidylcholine; PS, phosphatidylserine; PG, phosphatidylglycerol; CL, cardiolipin; PA, phosphatidic acid; PtdIns, phosphatidylinositol.